N. Bender

2.3k total citations
20 papers, 318 citations indexed

About

N. Bender is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Pharmacology. According to data from OpenAlex, N. Bender has authored 20 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Hematology and 4 papers in Pharmacology. Recurrent topics in N. Bender's work include Platelet Disorders and Treatments (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Blood Pressure and Hypertension Studies (4 papers). N. Bender is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Blood Pressure and Hypertension Studies (4 papers). N. Bender collaborates with scholars based in Germany, United Kingdom and United States. N. Bender's co-authors include JM Ritter, JR Cockcroft, D Vasmant, H. Fasold, Phil Chowienczyk, B Rangoonwala, M. Verho, Victoria Cairns, Christian Lück and W. J. Stelter and has published in prestigious journals such as FEBS Letters, European Journal of Biochemistry and Journal of Hypertension.

In The Last Decade

N. Bender

19 papers receiving 287 citations

Peers

Countries citing papers authored by N. Bender

Since Specialization

Citations

This map shows the geographic impact of N. Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Bender more than expected).

Fields of papers citing papers by N. Bender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Bender. The network helps show where N. Bender may publish in the future.

Co-authorship network of co-authors of N. Bender

This figure shows the co-authorship network connecting the top 25 collaborators of N. Bender. A scholar is included among the top collaborators of N. Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Bender. N. Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation 2013 ·Journal of Thrombosis and Thrombolysis ·Fabiana Rollini, Antonio Tello‐Montoliu, (unknown), Andrew Darlington, (unknown), Francesco Franchi, (unknown), Bhaloo Desai, N. Bender, Kjell S. Sakaríassen, Dominick J. Angiolillo	12
2	Gene therapy: a concept for the future in medical practice? The current state. 2004 ·PubMed ·N. Bender	1
3	Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies 2002 ·Thrombosis Research ·Sarfraz Ahmad, Sylvia Haas, Debra A. Hoppensteadt, (unknown), (unknown), N. Bender, Harry L. Messmore, Frank Misselwitz, Peter Bacher, (unknown), Walter Jeske, Jeanine M. Walenga, Jawed Fareed	24
4	Pharmacokinetics, metabolism and biliary and urinary excretion of oral ramipril in man 1995 ·Current Medical Research and Opinion ·M. Verho, Christian Lück, W. J. Stelter, B Rangoonwala, N. Bender	23
5	Inhibition of bradykinin‐induced vasodilation in human forearm vasculature by icatibant, a potent B2‐receptor antagonist. 1994 ·British Journal of Clinical Pharmacology ·JR Cockcroft, Phil Chowienczyk, (unknown), N. Bender, JM Ritter	80
6	Multiple-Dose Pharmacokinetics of Ramipril in Patients with Chronic Congestive Heart Failure 1993 ·Journal of Cardiovascular Pharmacology ·Bernhard Heintz, M. Verho, D. Brockmeier, (unknown), (unknown), H. G. Sieberth, B Rangoonwala, N. Bender	9
7	Combination of ramipril and hydrochlorothiazide in the treatment of mild to moderate hypertension—part 2: An open long‐term study of efficacy and safety 1993 ·Clinical Cardiology ·(unknown), (unknown), (unknown), Victoria Cairns, (unknown), N. Bender	4
8	Short report: Ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design 1993 ·Journal of Hypertension ·(unknown), Victoria Cairns, (unknown), N. Bender, (unknown), (unknown), James A. Phillips, (unknown), Gary G. Koch	30
9	Combination of ramipril and hydrochlorothiazide in the treatment of mild to moderate hypertension: Part 1—a double‐blind, comparative, multicenter study in nonresponders to ramipril monotherapy 1992 ·Clinical Cardiology ·(unknown), (unknown), (unknown), Victoria Cairns, N. Bender, (unknown)	12
10	Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications. 1990 ·PubMed ·N. Bender, B Rangoonwala, J. Rosenthal, D Vasmant	9
11	The Renin-Angiotensin System and Ramipril, A New Converting Enzyme Inhibitor 1989 ·Journal of Cardiovascular Pharmacology ·D Vasmant, N. Bender	24
12	The Renin-Angiotensin System and Ramipril, A New Converting Enzyme Inhibitor 1989 ·Journal of Cardiovascular Pharmacology ·D Vasmant, N. Bender	3
13	Evaluation of the Biological Effects of Low-Molecular-Weight Heparins 1988 ·Pathophysiology of Haemostasis and Thrombosis ·N. Bender, Christian Seidl, W. Weichert, (unknown)	5
14	On the Mechanism of Platelet Activation During Hemostasis and Thrombosis and on the Effects of Platelet Inhibiting Drugs 1984 ·Advances in experimental medicine and biology ·K Breddin, N. Bender, C.M. Kirchmaier	1
15	Stimulation of blood platelets by extracts of subcutaneous tissue 1979 ·Thrombosis Research ·N. Bender, C.M. Kirchmaier, Brigitte Bartsch, (unknown), K Breddin	7
16	A hemostasis activating factor (HAF) in subcutaneous tissue extracts: Effects on morphologic platelet changes, platelet retention and platelet aggregation 1979 ·Thrombosis Research ·C.M. Kirchmaier, N. Bender, (unknown), (unknown), K Breddin	6
17	The Selective Blocking of the Polymerization Reaction of Striated Muscle Actin Leading to a Derivative Suitable for Crystallization 1976 ·European Journal of Biochemistry ·N. Bender, H. Fasold, (unknown), (unknown), (unknown)	53
18	Artificial Dimers of Actin 1975 ·Biochemical Society Transactions ·H. Fasold, Hans G. Bäumert, N. Bender	4
19	Interaction of rabbit muscle actin and chemically modified actin with ATP, ADP, and protein reactive analogues; role of the nucleotide 1974 ·FEBS Letters ·N. Bender, H. Fasold, Michael Rack	4
20	Interaction of rabbit muscle actin and chemically modified actin with ATP, ADP, and protein reactive analogues; role of the nucleotide 1974 ·FEBS Letters ·N. Bender, H. Fasold, Michael Rack	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact